{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:57:11Z","timestamp":1792421831393,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bmcl.2024.130036","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T16:17:23Z","timestamp":1732292243000},"page":"130036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis and bioactivity evaluation of cinnamic acid derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury"],"prefix":"10.1016","volume":"116","author":[{"given":"Pengqin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.130036_b0005","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.3390\/cells11203317","article-title":"Therapeutic targeting of NF-\u03baB in acute lung injury: a double-edged sword","volume":"11","author":"Millar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2024.130036_b0010","article-title":"Advances in the use of exosomes for the treatment of ALI\/ARDS","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2024.130036_b0015","article-title":"Role of endoplasmic reticulum autophagy in acute lung injury","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmcl.2024.130036_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2012.01.053","article-title":"Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug","volume":"50","author":"Hayashi","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130036_b0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.arcmed.2020.08.002","article-title":"A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury\/Acute Respiratory Distress Syndrome in Patients with COVID-19","volume":"51","author":"Sahebnasagh","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.bmcl.2024.130036_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115412","article-title":"Design, synthesis and anti-inflammatory activity study of lansiumamide analogues for treatment of acute lung injury","volume":"166","author":"Song","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmcl.2024.130036_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1039\/C3NP70063A","article-title":"Natural products as starting points for the synthesis of complex and diverse compounds","volume":"31","author":"Morrison","year":"2014","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmcl.2024.130036_b8","doi-asserted-by":"crossref","first-page":"112660","DOI":"10.1016\/j.ejmech.2020.112660","article-title":"Recent developments of small molecules with anti-inflammatory activities for the treatment of acute lung injury","volume":"207","author":"Chen","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130036_b0040","doi-asserted-by":"crossref","unstructured":"UK prospective diabetes study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837\u2013853.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.bmcl.2024.130036_b0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat Chem"},{"key":"10.1016\/j.bmcl.2024.130036_b0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/ml400452v","article-title":"Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar","volume":"5","author":"Chelliah","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.130036_b0055","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bmcl.2024.130036_b0060","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.3390\/ijms21165712","article-title":"Cinnamic Acid Derivatives and Their Biological Efficacy","volume":"21","author":"Ruwizhi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2024.130036_b0065","article-title":"Plant-derived and dietary phenolic cinnamic acid derivatives: Anti-inflammatory properties","author":"Freitas","year":"2024","journal-title":"Food Chem. Published Online June 26"},{"key":"10.1016\/j.bmcl.2024.130036_b0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2174\/138955712801264792","article-title":"Antioxidant and antimicrobial activities of cinnamic acid derivatives","volume":"12","author":"Sova","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2024.130036_b0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2016.08.013","article-title":"Trans-cinnamaldehyde improves memory impairment by blocking microglial activation through the destabilization of iNOS mRNA in mice challenged with lipopolysaccharide","volume":"110","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmcl.2024.130036_b0080","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4039472","article-title":"Trans-Cinnamaldehyde Inhibits IL-1\u03b2-Stimulated Inflammation in Chondrocytes by Suppressing NF-\u03baB and p38-JNK Pathways and Exerts Chondrocyte Protective Effects in a Rat Model of Osteoarthritis","volume":"2019","author":"Xia","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmcl.2024.130036_b0085","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.119.262907","article-title":"Cinnamaldehyde Inhibits Inflammation of Human Synoviocyte Cells Through Regulation of Jak\/Stat Pathway and Ameliorates Collagen-Induced Arthritis in Rats","volume":"373","author":"Cheng","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2024.130036_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/1389557520666200820133252","article-title":"Advancement in Pharmacological Activities of Benzothiazole and its Derivatives: An Up to Date Review","volume":"21","author":"Sumit","year":"2021","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmcl.2024.130036_b0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.imbio.2004.05.003","article-title":"Immunomodulating effects of cefodizime on Klebsiella pneumoniae-stimulated neutrophils","volume":"209","author":"Song","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.bmcl.2024.130036_b0100","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.3390\/molecules26113166","article-title":"Thiazole Ring-A Biologically Active Scaffold","volume":"26","author":"Petrou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2024.130036_b0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2018.09.068","article-title":"Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury","volume":"161","author":"Chen","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.130036_b0110","unstructured":"Analytic data of potent compound 22: 2-aminobenzothiazole (150.03 mg, 1.00 mmol) was dissolved in the mixture of DCM and THF. Subsequently, NaH (26.4 mg, 1.1 mmol) was added. After 5 minutes, cinnamyl chloride (182.26 mg, 1.1 mmol) was added and the solution underwent a reaction at room temperature for 2 hours. The reaction was monitored by TLC. Once the reaction was completed, water was added and extraction was carried out with EA. The crude product was purified using flash column chromatography (PE: EA=3:1) to get yellow powder in 57.63% yield, mp 182.3-183.1 \u2103. 1H NMR (400 MHz, DMSO-d6) \u03b4 12.61 (s, 1H), 8.00 (d, J = 7.8 Hz, 1H), 7.79 (t, J = 12.7 Hz, 2H), 7.67 (d, J = 5.6 Hz, 2H), 7.46 (dd, J = 14.1, 6.8 Hz, 4H), 7.32 (t, J = 7.4 Hz, 1H), 6.97 (d, J = 15.8 Hz, 1H). 13C NMR (125 MHz, DMSO-d6) \u03b4 166.73, 154.45, 148.01, 143.12, 133.97, 131.51, 130.19, 129.33 \u00d7 2, 128.75 \u00d7 2, 124.85, 120.76, 118.74, 117.21, 112.87. Purity 99.00%, tR = 3.349 min. ESI-MS m\/z: 281.07 [M+H]+."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24004384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24004384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:19:26Z","timestamp":1733962766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24004384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":23,"alternative-id":["S0960894X24004384"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130036","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and bioactivity evaluation of cinnamic acid derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.130036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130036"}}